http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2018001899-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-06
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 2018-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_896e2c8810106a19419155cd1a6c7ad0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62969bb7fcd8590e7c49fe73b6844086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c96afbf62b5b4741d3dccc8f23084ace
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30a4c5c08327ee0ebd8c730a5ffa06fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_970ae3d168fac5265e0224f9006c0e09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c56dfbca1664b105c1ccf74253c177e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6604bd88642bcc19d2676cdb0f6ffd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc11df3bb548740aad86bbb8f44d0d4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8067136db21f15544826c5fbfa62fe52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45ba971efd38b7c74e7cb5f3494562f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f14706fa730a7d207793842f3906bdf
publicationDate 2018-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2018001899-A1
titleOfInvention Spiroheptane salicylamides and related compounds such as rho kinase inhibitors (rock)
abstract THE PRESENT INVENTION REFERS TO FORMULA (S), STEREOISOMETER, TAUTOMETER OR PHARMACEUTICALLY ACCEPTABLE SALES COMPOUNDS OF THE SAME, AS SELECTIVE ROCK INHIBITORS, WHERE ALL THE VARIABLES ARE PRESENT AS DEFINED. IT ALSO REFERS TO PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM AND METHODS TO TREAT CARDIOVASCULAR DISORDERS, RELATED TO THE SMOOTH, ONCOLOGICAL, NEUROPATOLOGICAL, AUTOIMMUNATORY / MEDICAL USE.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10793556-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10807988-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10829480-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10807989-B2
priorityDate 2016-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474861

Total number of triples: 51.